Dividend
-
-
-
-
-
-
-
Amgen (AMGN), AstraZeneca (AZN) Say Tezepelumab Is First Biologic To Significantly Reduce Exacerbations In Broad Population Of Patients With Severe, Uncontrolled Asthma
-
-
-
-
-
-
-
Australia's CSL to manufacture two COVID-19 vaccines, shares up
-
-
-
-
-
-
-
GSK's R&D head to leave for top UK government job: source
-
-
-
-
-
-
-
Market Wrap: Markets Readjust to Rate Hike; Shkreli Under Fire; Apple Names First COO Since Cook
-
-
-
-
-
-
-
Market Wrap: BofA Rethinks Capital Plan; Two Mergers Dematerialize; Alstom Attracts Siemens Eye
-
-
-
-
-
-
-
Unusual 11 Mid-Day Movers 05/28: (OMTH) (PIP) (BLDP) Higher; (ENOC) (VIPS) (BDL) Lower
-
-
-
-
-
-
-
AstraZeneca (AZN) Misses Q2 EPS by 7c; Raises FY11 EPS Outlook; Recommends Dividend; Potential Increase in Buybacks
-
377,510 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All